Bluesky Facebook Reddit Email

New tech speeds up AI training for drug discovery/disease research

08.14.25 | University of Oregon

Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

University of Oregon bioengineer Calin Plesa has developed technology that creates massive, high-quality biological datasets at unprecedented speed and scale, solving a critical bottleneck that has prevented AI from tackling biology's biggest challenges—from studying cancer-associated genes to designing new proteins to accelerating drug development. In research detailed in the latest edition of Science Advances , Plesa used this technology to uncover genetic factors behind antimicrobial resistance, demonstrating how to generate the vast datasets needed to train powerful machine learning systems faster and cheaper than ever before.

Science Advances

Exploring Antibiotic Resistance in Diverse Homologs of the Dihydrofolate Reductase Protein Family through Broad Mutational Scanning

14-Aug-2025

Keywords

Article Information

Contact Information

Molly Blancett
University of Oregon
blancett@uoregon.edu

How to Cite This Article

APA:
University of Oregon. (2025, August 14). New tech speeds up AI training for drug discovery/disease research. Brightsurf News. https://www.brightsurf.com/news/8X5ZKK01/new-tech-speeds-up-ai-training-for-drug-discoverydisease-research.html
MLA:
"New tech speeds up AI training for drug discovery/disease research." Brightsurf News, Aug. 14 2025, https://www.brightsurf.com/news/8X5ZKK01/new-tech-speeds-up-ai-training-for-drug-discoverydisease-research.html.